There are two different international standards for the treatment of follicular lymphoma (FL):
intensified therapy followed by autologous stem‐cell transplantation (ASCT) and …

Background The impact of high-dose therapy and autologous stem cell transplantation
(ASCT) vs conventional-dose chemotherapy in the initial management of adults with …

Background Follicular lymphoma (FL) is the most common indolent and second most
common Non‐Hodgkins lymphoma (NHL) in the Western world. Standard treatment usually …

Autologous stem cell transplantation (ASCT) as first-line therapy for follicular lymphoma (FL)
remains controversial. The multicenter study randomized 172 patients with untreated FL for …

Background: The effect of autologous hematopoietic stem cell transplantation (auto-HSCT)
versus conventional chemotherapy or allogeneic hematopoietic stem cell transplantation …

Background: Patients with high-risk FL intensified with HDT/ASCT may achieve prolonged
remissions. The best timing for the procedure remains controversial. Patients who are …

Background Among the 566 patients with follicular lymphomas (FL) included in the GELF 86
prospective trials from October 1986 to September 1995, 372 with progressive/relapsing …

Objective: This review will evaluate the effectiveness of dose-intensified versus standard-
dose salvage regimens on progression-free survival in early progressed follicular lymphoma …

Published studies have provided conflicting results regarding the curative potential of high
dose chemotherapy and autologous stem cell transplant (HDT/ASCT) for follicular …

Objective To contribute data on long‐term outcome and potential curative impact of ASCT in
FL, especially following HDT with the BEAM protocol (BCNU, etoposide, cytarabine and …